MARKET IS CLOSED
Loading latest tickers...
Market Indices
S&P 500
$7,722.72
+0.73%
NASDAQ 100
$30,807.93
+1.00%
DOW JONES
$51,177.00
+0.49%
NASDAQ Composite
$27,190.86
+1.19%
RUSSELL 2000
$2,815.20
+0.90%
CBOE VIX
$15.31
-6.59%
Sector Heatmap
Technology+1.01%
Financials+0.06%
Healthcare-0.01%
Consumer Cycl+1.13%
Consumer Staples+0.25%
Energy+0.40%
Industrials+0.78%
Materials+0.66%
Real Estate+0.32%
Utilities+0.38%
Comm Services+0.35%
ASBP — Aspire Biopharma Holdings, Inc. Common Stock
NasdaqAspire Biopharma Holdings, Inc. Common Stock
$8.78
+0.66(+8.13%)
- O
- 8.37
- H
- 8.81
- L
- 8.33
- V
- 16.53K
⏱️ End-of-day dataAs of Oct 2, 2026
ASBP — Financial Statements
Historical 2-Year Statements| Financial Metric / Line Item | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 |
|---|---|---|---|---|---|---|
| Fiscal Date | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
| Period | quarterly | quarterly | quarterly | quarterly | quarterly | quarterly |
| Year | 2,026.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,025.00 | 2,024.00 |
| Cash | $5.86M | $1.00M | $1.95M | 206,233.00 | $1.35M | 3,633.00 |
| Cash And Cash Equivalents | $5.86M | $1.00M | $1.95M | 206,233.00 | $1.35M | 3,633.00 |
| Inventory | 369,974.00 | 253,160.00 | 35,437.00 | N/A | N/A | N/A |
| Other Current Assets | 890,149.00 | 55,102.00 | 419,421.00 | 783,189.00 | N/A | N/A |
| Total Current Assets | $7.12M | $1.31M | $2.40M | 989,422.00 | $1.97M | 147,989.00 |
| Total Non Current Assets | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Total Assets | $7.12M | $1.31M | $2.40M | 989,422.00 | $1.97M | 147,989.00 |
| Accounts Payable | 857,925.00 | $1.01M | $1.06M | $1.35M | $1.43M | 310,219.00 |
| Accrued Expenses | 441,614.00 | $1.01M | 266,930.00 | 378,181.00 | 319,067.00 | N/A |
| Short Term Debt | $1.50M | $5.18M | $8.62M | $8.47M | $6.76M | $1.27M |
| Total Current Liabilities | $3.15M | $7.59M | $13.86M | $10.56M | $8.87M | $1.69M |
| Derivative Product Liabilities | 96,252.00 | 95,662.00 | 9,901.00 | 49,285.00 | 49,303.00 | N/A |
| Total Non Current Liabilities | 96,252.00 | 95,662.00 | 9,901.00 | 49,285.00 | 49,303.00 | 0.00 |
| Total Liabilities | $3.25M | $7.69M | $13.87M | $10.61M | $8.92M | $1.69M |
| Common Stock | 17.00 | 353.00 | 4,953.00 | 4,953.00 | 4,890.00 | 22,000.00 |
| Retained Earnings | $-30.48M | $-27.26M | $-22.55M | $-20.70M | $-18.72M | $-2.78M |
| Total Shareholders Equity | $3.87M | $-6.38M | $-11.47M | $-9.62M | $-6.95M | $-1.54M |
| Additional Paid In Capital | $34.35M | $20.88M | $11.08M | $11.08M | $11.76M | $1.22M |
| Prepaid Assets | N/A | 55,102.00 | 419,421.00 | 783,189.00 | 618,971.00 | 144,356.00 |
| Other Current Liabilities | N/A | 40,954.00 | $3.55M | N/A | N/A | 111,026.00 |